Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02793674 · ClinicalTrials.gov registry record · NA
HFNC Flow Titration and Effort of Breathing in the PICU
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02793674 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 21 participants.
The verdict
NCT02793674, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
High-flow nasal cannula (HFNC) is a method of non-invasive respiratory support used to decrease the effort of breathing (EOB) in patients with a wide variety of respiratory diseases in the pediatric intensive care unit. While its use has shown association with decreased rates of mechanical ventilation, there is a paucity of data examining its direct effect upon objective measurements of EOB. This study will aim to evaluate objective measurements of EOB in response to different levels of HFNC support, characterize the natural course of respiratory diseases treated with HFNC, evaluate changes in EOB secondary to the administration of supplemental medical therapies used in conjunction with HFNC, and compare different physiologic metrics for quantifying EOB in patients on HFNC.
Interventions
- DEVICE Fisher & Paykel high flow nasal cannula
- DEVICE Vapotherm high flow nasal cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02793674
The ClinicalTrials.gov registry entry for NCT02793674 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fisher & Paykel high flow nasal cannula is the first listed.
NCT02793674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02793674 about?
NCT02793674 is a clinical study titled "HFNC Flow Titration and Effort of Breathing in the PICU". High-flow nasal cannula (HFNC) is a method of non-invasive respiratory support used to decrease the effort of breathing (EOB) in patients with a wide variety of respiratory diseases in the pediatric intensive care unit. While its use has shown association with decreased rates of mechanical ventilati...
What is the current status of trial NCT02793674?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2014-09. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02793674?
The interventions under investigation include: Fisher & Paykel high flow nasal cannula (DEVICE), Vapotherm high flow nasal cannula (DEVICE).
Who is sponsoring clinical trial NCT02793674?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.